無針注射システム市場は、2021年の1億2400万ドルから2026年までに2億7200万ドルに達し、2020年から2026年までのCAGRは17.0％と予想されます。この市場の成長を推進する主な要因は、技術の進歩、自己注射装置の需要の増加、および慢性疾患の発生率の上昇です。 高齢者人口の増加と慢性疾患の有病率の増加に伴い、世界的に患者数が大幅に増加しています。これにより、無針注射システムの使用を含む、先進的で効果的な治療法に対する需要が高まっています。さらに、世界中で高度なドラッグデリバリー技術が広く採用されていることが、この市場の成長を支えています。一方、大量および静脈内投与システムの制約が市場の成長を阻む重要な要因です。
目次
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 KEY INDUSTRIAL INSIGHTS
2.5 LIMITATIONS
2.6 RISK ASSESSMENT
2.7 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE NEEDLE-FREE INJECTION SYSTEM MARKET
5.4 PRICING ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
5.6 PATENT ANALYSIS
5.7 ECOSYSTEM MARKET MAP
5.8 VALUE CHAIN ANALYSIS
5.9 TECHNOLOGY ANALYSIS
5.10 REGULATORY LANDSCAPE
5.11 PORTER’S FIVE FORCES ANALYSIS
6 NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT (USD MILLION; 2019-2026)
6.1 INTRODUCTION
6.2 FILLABLE NEEDLE-FREE INJECTORS
6.3 PREFILLED NEEDLE-FREE INJECTORS
7 NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY (USD MILLION; 2019-2026)
7.1 INTRODUCTION
7.2 JET-BASED NEEDLE-FREE INJECTORS
7.3 SPRING-BASED NEEDLE-FREE INJECTORS
7.4 MICRO ARRAY PATCH INJECTORS
7.5 OTHER TECHNOLOGIES
8 NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE (USD MILLION; 2019-2026)
8.1 INTRODUCTION
8.2 LIQUID-BASED NEEDLE-FREE INJECTORS
8.3 PROJECTILE/DEPOT-BASED NEEDLE-FREE INJECTORS
8.4 POWDER-BASED NEEDLE FREE INJECTORS
9 NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY (USD MILLION; 2019-2026)
9.1 INTRODUCTION
9.2 SUBCUTANEOUS INJECTORS
9.3 INTRAMUSCULAR INJECTORS
9.4 INTRADERMAL INJECTORS
10 NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION (USD MILLION; 2019-2026)
10.1 INTRODUCTION
10.2 VACCINE DELIVERY
10.3 INSULIN DELIVERY
10.4 ONCOLOGY
10.5 PAIN MANAGEMENT
10.6 DERMATOLOGY
10.7 OTHER APPLICATIONS
11 NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USER (USD MILLION; 2019-2026)
11.1 INTRODUCTION
11.2 HOSPITALS
11.3 HOME CARE SETTINGS
11.4 RESEARCH LABORATORIES
11.5 PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
11.6 OTHER END USERS
12 NEEDLE-FREE INJECTION SYSTEM MARKET, BY REGION (USD MILLION; 2019-2026)
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 US
12.2.2 CANADA
12.3 EUROPE
12.3.1 GERMANY
12.3.2 FRANCE
12.3.3 UK
12.3.4 ITALY
12.3.5 SPAIN
12.3.6 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 JAPAN
12.4.2 CHINA
12.4.3 INDIA
12.4.4 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.13 MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGIES/ RIGHT TO WIN
13.3 REVENUE SHARE ANALYSIS
13.4 NEEDLE-FREE INJECTION SYSTEM MARKET RANKING
13.5 COMPANY EVALUATION QUADRANT
13.5.1 STARS
13.5.2 PERVASIVE PLAYERS
13.5.3 EMERGING LEADERS
13.5.4 PARTICIPANTS
13.6 COMPANY EVALUATION QUADRANT FOR START-UPS
13.6.1 PROGRESSIVE COMPANIES
13.6.2 DYNAMIC COMPANIES
13.6.3 STARTING BLOCKS
13.6.4 RESPONSIVE COMPANIES
13.7 COMPETITIVE BENCHMARKING
13.7.1 OVER ALL COMPANY FOOTPRINT
13.8 COMPETITIVE SCENARIO
13.8.1 PRODUCT LAUNCHES AND UPGRADES
13.8.2 DEALS
13.8.3 EXPANSIONS
14 COMPANY PROFILES
(Overview, Products, Financials, Strategy & Development)
14.1 KEY PLAYERS
14.1.1 PHARMJET
14.1.2 PORTAL INSTRUMENTS, INC.
14.1.3 MEDICAL INTERNATIONAL TECHNOLOGY, INC. (MIT)
14.1.4 NUGEN MEDICAL DEVICES
14.1.5 CROSSJECT
14.1.6 BIOJECT MEDICAL TECHNOLOGIES INC. (ACQUIRED BY INOVIO PHARMACEUTICALS, INC.)
14.1.7 ANTARES PHARMA, INC.
14.1.8 INJEX PHARMA GMBH
14.1.9 NATIONAL MEDICAL PRODUCTS, INC.
14.1.10 ZEALAND PHARMA A/S
14.2 OTHER PLAYERS
14.1.11 PENJET CORPORATION
14.1.12 ENESI PHARMA LIMITED
14.1.13 INTEGRIMEDICAL LLC
14.1.14 AKRA DERMOJET
14.1.15 D'ANTONIO CONSULTANTS INTERNATIONAL, INC
14.1.16 BASCO INDIA
14.1.17 MIKA MEDICAL CO
14.1.18 MADA MEDICAL PRODUCTS INC
14.1.19 VAXXAS
14.1.20 GUANGZHOU MEDSINGLONG MEDICAL EQUIPMENT CO., LTD
14.1.21 QUINOVARE
14.1.22 TAPEMARK
14.1.23 THERAJECT
14.1.24 ZOSANO PHARMA
14.1.25 CORIUM
15 APPENDIX
